Pricing Log in Create free account

AN2 Therapeutics, Inc. (ANTX) vs Korro Bio, Inc. (KRRO)

AN2 Therapeutics, Inc. and Korro Bio, Inc. are both Biotechnology companies. AN2 Therapeutics, Inc. and Korro Bio, Inc. are of similar size ($137.1M and $135.9M). Across the 9 metrics below, AN2 Therapeutics, Inc. leads on 6 and Korro Bio, Inc. on 3.

Valuation

Metric ANTX KRRO Biotechnology median
P/E n/m n/m 8.42
P/S n/m 25.66 10.01
P/B 2.12 1.59 2.21
Price to free cash flow n/m n/m 21.01
EV/EBITDA n/m n/m 0.61
EV/Sales n/m 10.53 9.41
Earnings yield (29.81%) (107.41%) (31.85%)
Free cash flow yield (19.09%) (41.62%) (24.58%)

Profitability

Metric ANTX KRRO Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (50.12%) (97.69%) (56.36%)
Return on assets (46.06%) (62.03%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ANTX KRRO Biotechnology median
Revenue growth (TTM) — (81.87%) 6.02%
EPS growth (last fiscal year) 32.56% (33.19%) 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ANTX KRRO Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 14.32 9.55 4.72
Net debt to EBITDA 1.48 0.64 0.96

Dividend

Metric ANTX KRRO Biotechnology median
Dividend yield — — 0.08%
Payout ratio — — —

Size

Metric ANTX KRRO Biotechnology median
Market cap 135.85m 137.09m 132.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack